Timmons, M. ., Bradley, M. ., Lovell, M. ., & Lynn, B. . (2011). Procedure for the isolation of mitochondria, cytosolic and nuclear material from a single piece of neurological tissue for high-throughput mass spectral analysis. Journal of Neuroscience Methods, 197(2), 279-82. https://doi.org/10.1016/j.jneumeth.2011.02.027 (Original work published 2011)

Lovell, M. ., Bradley, M. ., & Fister, S. . 4-Hydroxyhexenal (HHE) impairs glutamate transport in astrocyte cultures. Journal of Alzheimer’s Disease : JAD, 32(1), 139-46. https://doi.org/10.3233/JAD-2012-120409 (Original work published 2012)

Weidner, A. ., Bradley, M. ., Beckett, T. ., Niedowicz, D. ., Dowling, A. ., Matveev, S. ., … Murphy, M. . RNA oxidation adducts 8-OHG and 8-OHA change with Aβ42 levels in late-stage Alzheimer’s disease. PloS One, 6(9), e24930. https://doi.org/10.1371/journal.pone.0024930 (Original work published 2011)

Lovell, M. ., Soman, S. ., & Bradley, M. . (2011). Oxidatively modified nucleic acids in preclinical Alzheimer’s disease (PCAD) brain. Mechanisms of Ageing and Development, 132(8-9), 443-8. https://doi.org/10.1016/j.mad.2011.08.003

Bradley, M. ., Xiong-Fister, S. ., Markesbery, W. ., & Lovell, M. . (2012). Elevated 4-hydroxyhexenal in Alzheimer’s disease (AD) progression. Neurobiology of Aging, 33(6), 1034-44. https://doi.org/10.1016/j.neurobiolaging.2010.08.016

Bradley, M. ., Markesbery, W. ., & Lovell, M. . (2010). Increased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer disease. Free Radical Biology & Medicine, 48(12), 1570-6. https://doi.org/10.1016/j.freeradbiomed.2010.02.016 (Original work published 2010)